SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016140
Filing Date
2022-11-03
Accepted
2022-11-03 07:45:42
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20220930x10q.htm   iXBRL 10-Q 2520789
2 EX-10.1 bcyc-20220930xex10d1.htm EX-10.1 44034
3 EX-31.1 bcyc-20220930xex31d1.htm EX-31.1 14094
4 EX-31.2 bcyc-20220930xex31d2.htm EX-31.2 14300
5 EX-32.1 bcyc-20220930xex32d1.htm EX-32.1 10830
  Complete submission text file 0001558370-22-016140.txt   9268465

Data Files

Seq Description Document Type Size
6 EX-101.SCH bcyc-20220930.xsd EX-101.SCH 73776
7 EX-101.CAL bcyc-20220930_cal.xml EX-101.CAL 52810
8 EX-101.DEF bcyc-20220930_def.xml EX-101.DEF 282671
9 EX-101.LAB bcyc-20220930_lab.xml EX-101.LAB 543696
10 EX-101.PRE bcyc-20220930_pre.xml EX-101.PRE 437603
75 EXTRACTED XBRL INSTANCE DOCUMENT bcyc-20220930x10q_htm.xml XML 1499910
Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 221356281
SIC: 2834 Pharmaceutical Preparations